Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Julphar
Teva
Healthtrust
Cipla

Generated: April 20, 2019

DrugPatentWatch Database Preview

Filgrastim - Biologic Drug Details

« Back to Dashboard

Summary for filgrastim
Tradenames:1
Patents:175
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for filgrastim

US Patents for filgrastim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up Washington University (St. Louis, MO) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for filgrastim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0100006 00032 Estonia ➤ Sign Up PRODUCT NAME: REVOLADE-ELTROMBOPAG; REG NO/DATE: C(2010)1662 11.03.2010
2003 Austria ➤ Sign Up PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
2003 Austria ➤ Sign Up PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
02C/040 Belgium ➤ Sign Up PRODUCT NAME: PEGFILGRASTIM; AUTHORISATION NUMBER AND DATE: EU/1/02/227/001 20020823
6 Finland ➤ Sign Up
00687 Netherlands ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cipla
McKinsey
US Department of Justice
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.